BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24308225)

  • 1. Definition of acetylsalicylic acid resistance using whole blood impedance aggregometry in patients undergoing coronary artery surgery.
    Petricević M; Biocina B; Konosić S; Burcar I; Sirić F; Mihaljević MZ; Ivancan V; Svetina L; Gasparović H
    Coll Antropol; 2013 Sep; 37(3):833-9. PubMed ID: 24308225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy.
    Petricevic M; Biocina B; Konosic S; Kopjar T; Kunac N; Gasparovic H
    Heart Vessels; 2013 Jan; 28(1):57-65. PubMed ID: 22203409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
    Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of monitoring platelet function by multiple electrode aggregometry in primary coronary artery bypass surgery.
    Mengistu AM; Mayer J; Boldt J; Röhm KD; Suttner SW
    J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):42-7. PubMed ID: 20427204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
    Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
    Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative bleeding in coronary artery bypass patients on double antiplatelet therapy: predictive value of preoperative aggregometry.
    Della Corte A; Bancone C; Spadafora A; Borrelli M; Galdieri N; Quintiliano SN; Bifulco O; De Feo M
    Eur J Cardiothorac Surg; 2017 Nov; 52(5):901-908. PubMed ID: 28977378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding risk assessment using multiple electrode aggregometry in patients following coronary artery bypass surgery.
    Petricevic M; Biocina B; Milicic D; Konosic S; Ivancan V; Milosevic M; Burcar I; Gasparovic H
    J Thromb Thrombolysis; 2013 Jan; 35(1):31-40. PubMed ID: 22926758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
    Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional evaluation of platelet aspirin resistance after on-pump coronary bypass grafting using multiple aggregation tests.
    Kammerer I; Bach J; Saggau W; Isgro F
    Thorac Cardiovasc Surg; 2011 Oct; 59(7):425-9. PubMed ID: 21437867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
    Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor.
    Barbieri L; Verdoia M; Pergolini P; Nardin M; Rolla R; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2016 Apr; 26(4):352-8. PubMed ID: 26857781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of false results in the assessment of platelet function in the absence of antiplatelet medication: comparison of the PFA-100, multiplate electrical impedance aggregometry and verify now assays.
    Can MM; Tanboğa IH; Türkyilmaz E; Karabay CY; Akgun T; Koca F; Tokgoz HC; Keles N; Ozkan A; Bezgin T; Ozveren O; Sonmez K; Sağlam M; Ozdemir N; Kaymaz C
    Thromb Res; 2010 Apr; 125(4):e132-7. PubMed ID: 19954823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation.
    Eshtehardi P; Windecker S; Cook S; Billinger M; Togni M; Garachemani A; Meier B; Hess OM; Wenaweser P
    Am Heart J; 2010 May; 159(5):891-898.e1. PubMed ID: 20435201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study.
    Velik-Salchner C; Maier S; Innerhofer P; Streif W; Klingler A; Kolbitsch C; Fries D
    Anesth Analg; 2008 Dec; 107(6):1798-806. PubMed ID: 19020120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring ASA and P2Y12-specific platelet inhibition--comparison of conventional (single) and multiple electrode aggregometry.
    Krüger JC; Meves SH; Kara K; Mügge A; Neubauer H
    Scand J Clin Lab Invest; 2014 Oct; 74(7):568-74. PubMed ID: 25296945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monitoring of antiaggregation effect of acetylsalicylic acid therapy by measuring serum thromboxane B2 in patients with coronary artery bypass grafting.
    Klasic A; Lakusic N; Gaspar L; Kruzliak P
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):370-3. PubMed ID: 26575493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry.
    Motovska Z; Sujanova Z; Wimmerova S; Ardo J; Skrakova M; Widimsky P
    Transl Res; 2007 Oct; 150(4):246-52. PubMed ID: 17900512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.